Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-11-4
pubmed:abstractText
Autoantibodies to SOXB1 antigens are commonly found in patients with small-cell lung cancer (SCLC). It has not been established whether the presence of circulating SOX antibodies is associated with a specific paraneoplastic clinical phenotype, or if a tumour immune response to SOX antigens can affect prognosis in patients with SCLC in relation to other established prognostic factors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1872-8332
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
335-9
pubmed:meshHeading
pubmed-meshheading:20371131-Adult, pubmed-meshheading:20371131-Aged, pubmed-meshheading:20371131-Aged, 80 and over, pubmed-meshheading:20371131-Autoantibodies, pubmed-meshheading:20371131-Autoimmunity, pubmed-meshheading:20371131-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:20371131-Female, pubmed-meshheading:20371131-Follow-Up Studies, pubmed-meshheading:20371131-Humans, pubmed-meshheading:20371131-Lung Neoplasms, pubmed-meshheading:20371131-Male, pubmed-meshheading:20371131-Middle Aged, pubmed-meshheading:20371131-Prognosis, pubmed-meshheading:20371131-SOXB1 Transcription Factors, pubmed-meshheading:20371131-Sensitivity and Specificity, pubmed-meshheading:20371131-Small Cell Lung Carcinoma, pubmed-meshheading:20371131-Survival Analysis, pubmed-meshheading:20371131-Tumor Markers, Biological
pubmed:year
2010
pubmed:articleTitle
Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.
pubmed:affiliation
Department of Neurology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham NG7 2UH, UK. paul.maddison@nhs.net
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't